(19)
(11) EP 4 536 220 A1

(12)

(43) Date of publication:
16.04.2025 Bulletin 2025/16

(21) Application number: 23824449.5

(22) Date of filing: 09.06.2023
(51) International Patent Classification (IPC): 
A61K 31/395(2006.01)
A61K 31/485(2006.01)
A61K 31/33(2006.01)
 A61K 31/435(2006.01)
A61K 31/47(2006.01)
(52) Cooperative Patent Classification (CPC):
A61K 31/485; A61K 9/209; A61K 9/2013; A61K 9/2054
(86) International application number:
PCT/US2023/024903
(87) International publication number:
WO 2023/244502 (21.12.2023 Gazette 2023/51)
(84) Designated Contracting States:
AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC ME MK MT NL NO PL PT RO RS SE SI SK SM TR
Designated Extension States:
BA
Designated Validation States:
KH MA MD TN

(30) Priority: 13.06.2022 US 202217839453

(71) Applicant: Soin Therapeutics LLC
Dayton, Ohio 45458 (US)

(72) Inventors:
  • SINKAR, Shweta
    Dayton, Ohio 45458 (US)
  • GIANNINI, Robert
    Riverside, California 92503 (US)
  • SOIN, Amol
    Dayton, Ohio 45458 (US)

(74) Representative: Meissner Bolte Nürnberg 
Patentanwälte Rechtsanwälte Partnerschaft mbB Bankgasse 3
90402 Nürnberg
90402 Nürnberg (DE)

   


(54) METHODS OF USING LOW DOSE NALTREXONE TO TREAT CHRONIC PAIN